ARCHIVES

Letters to the Editor: Burzynski: Reviewers Sought To Discredit Antineoplaston Therapy

This article is from The Cancer Letter archive.

Vol. 24 No. 41 | October 30, 1998

Download PDF Visit The Full Archive

Related Articles

CCOP Review Competed, Enough Good Applications In Funding Range To Get Viable Program Started

February 18, 1983

NCI Advisory Group, Other Cancer Meetings

February 28, 1986

NCI to Fund 122 More Grants in FY04

March 28, 2003

ODAC Says Clear Clinical Benefit Required When Sponsors Claim Progression Delay

July 17, 2009

Center Program Move Definite; DCBD to Be Renamed

September 22, 1989

Pathology Review Confirms Reserpine As Carcinogen

March 14, 1980